CAR T-cell therapy (Atossa Genetics)

N/A

Report date: 2025/03/14 16:51:06

Base Information

Drug NameCAR T-cell therapy (Atossa Genetics)

Drug Alias NameTRAP CAR-T cell therapy (Atossa Genetics)chimeric antigen receptor therapy (Atossa Genetics)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionT lymphocytes stimulantsImmunostimulants

TargetsUpdating

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAtossa Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesAtossa Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A